Ok Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
May 12, 2020 at 04:25 pm EDT
Share
OK Biotech Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 370.790 million compared to TWD 281.925 million a year ago. Operating income was TWD 45.765 million compared to TWD 23.394 million a year ago. Net income was TWD 46.674 million compared to TWD 29.165 million a year ago. Basic earnings per share was TWD 0.61 compared to TWD 0.39 a year ago. Diluted earnings per share was TWD 0.57 compared to TWD 0.38 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
